Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Bryan Vartabedian

Peds GI · Texas Children's Hospital

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Richard Dutton

General Anesthesiology · UMSOM

View

Dr. Sarah Ro

Obesity Medicine · UNC Health Care

View

Dr. Rebecca Andrews

Primary Care · UCHC

View

Dr. Jed Wolpaw

General Anesthesiology · Johns Hopkins

View

Dr. Matt Sherrer

Perioperative Med · UAB

View

Dr. David Bates

General Internal Medicine · BWH

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    ESDr. Elizabeth A. Spencer

    Dr. Elizabeth A. Spencer

    Pediatric Gastroenterology · Pediatric Inflammatory Bowel Disease Gastroenterology
    Icahn School of Medicine at Mount Sinai
    elizabethspencer
    New York City, NY, USA

    Research

    Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Diseases

    2026

    Via Inflamm Bowel Dis

    Research

    Prevalence, age-distribution, and impact on management of acne in patients on upadacitinib for inflammatory bowel disease: insights from a single-center survey

    2026

    Via Crohns Colitis 360

    Research

    Subcutaneous infliximab in pediatric inflammatory bowel disease: Sustained remission, predictable pharmacokinetics, and real-world US implementation

    2026

    Via J Pediatr Gastroenterol Nutr

    Research

    Comparable 12-Week and Superior 24-Week Remission With Risankizumab vs Ustekinumab for Crohn's-Like Disease of the Pouch

    2026

    Via Clin Gastroenterol Hepatol

    Research

    Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-Week Multicenter Study From the Porto Group of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition

    2026

    Via Clin Gastroenterol Hepatol

    Research

    The Impact of Gender, Rank, and Race on Industry Payments in Pediatric and Adult Gastroenterology

    2026

    Via Dig Dis Sci

    Research

    Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease

    2025

    Via Pharmaceutics

    Research

    Long-term VEDOKIDS results: implications for practice and research

    2025

    Via Lancet Gastroenterol Hepatol

    Research

    Early intestinal ultrasound response to biologic and small molecule therapy is accurate to predict treat-to-target endoscopic outcomes in children with ulcerative colitis: results from the prospective super sonic-UC study

    2025

    Via J Crohns Colitis

    Research

    Patient and First-Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease-A Multinational Survey

    2025

    Via United European Gastroenterol J

    Research

    Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion

    2025

    Via Inflamm Bowel Dis

    Research

    Sonographic Transmural Induction Outcomes Across Advanced Therapies in Crohn's Disease

    2025

    Via Dig Dis Sci

    Research

    Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease

    2024

    Via Inflamm Bowel Dis

    Research

    Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease families

    2024

    Via Gut

    Research

    Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1∗05 Carriage Is Associated With Antidrug Antibody Formation in Patients With Inflammatory Bowel Disease

    2022

    Via Gastroenterology